Randomized Controlled Trial of Humidified High-Flow Nasal Oxygen for Acute Respiratory Distress in the Emergency Department: The HOT-ER Study.

Content Provider	Semantic Scholar
Author	Jones, Peter Kamona, Sinan Doran, Owen Sawtell, Frann Wilsher, Margaret L.
Copyright Year	2016
Abstract	BACKGROUND Humidified high-flow nasal cannula (HFNC) is a novel method of oxygen delivery with increasing use in emergency departments and intensive care settings despite little evidence showing benefit over standard oxygen delivery methods (standard O2). The aim of this study was to determine whether HFNC compared with standard O2 given to subjects in acute respiratory distress would reduce the need for noninvasive ventilation or invasive ventilation. METHODS This was a pragmatic open randomized controlled trial in adult subjects with hypoxia and tachypnea presenting to a tertiary academic hospital emergency department. The primary outcome was the need for mechanical ventilation in the emergency department. RESULTS We screened 1,287 patients, 322 met entry criteria and 19 were excluded from analysis. Of these, 165 randomized to HFNC and 138 to standard O2 were analyzed. Baseline characteristics were similar. In the HFNC group, 3.6% (95% CI 1.5-7.9%) versus 7.2% (95% CI 3.8-13%) in the standard O2 group required mechanical ventilation in the emergency department (P = .16), and 5.5% (95% CI 2.8-10.2%) in HFNC versus 11.6% (95% CI 7.2-18.1%) in the standard O2 group required mechanical ventilation within 24 h of admission (P = .053). There was no difference in mortality or stay. Adverse effects were infrequent; however, fewer subjects in the HFNC group had a fall in Glasgow coma score due to CO2 retention, 0% (95% CI 0-3%) versus 2.2% (95% CI 0.4-6%). One in 12 subjects did not tolerate HFNC. CONCLUSIONS HFNC was not shown to reduce the need for mechanical ventilation in the emergency department for subjects with acute respiratory distress compared with standard O2, although it was safe and may reduce the need for escalation of oxygen therapy within the first 24 h of admission.
File Format	PDF HTM / HTML
DOI	10.4187/respcare.04252
PubMed reference number	26577199
Journal	Medline
Volume Number	61
Issue Number	3
Alternate Webpage(s)	http://rc.rcjournal.com/content/respcare/61/3/291.full.pdf
Alternate Webpage(s)	http://rc.rcjournal.com/content/respcare/early/2015/11/24/respcare.04252.full.pdf
Alternate Webpage(s)	https://doi.org/10.4187/respcare.04252
Journal	Respiratory care
Language	English
Access Restriction	Open
Content Type	Text
Resource Type	Article